Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients

Atherosclerosis

Volumn 241, Issue 1, 2015, Pages 192-198

  Kotur Stevuljevic, Jelena ^a   Bogavac Stanojevic, Natasa ^a   Jelic Ivanovic, Zorana ^a   Stefanovic, Aleksandra ^a   Gojkovic, Tamara ^a   Joksic, Jelena ^a   Sopic, Miron ^a   Gulan, Brankica ^b   Janac, Jelena ^a   Milosevic, Sanja ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Special Hospital for Cerebrovascular Diseases 'Sveti Sava'   (Serbia)

^c Health Center Hospital Zaje ar   (Serbia)

Author keywords

High density lipoprotein; Oxidative stress; Paraoxonase 1; Stroke

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; THIOL DERIVATIVE; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; PON1 PROTEIN, HUMAN;

ADULT; ADVERSE OUTCOME; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; STROKE PATIENT; SURVIVAL; AGED; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL; STROKE;

ADULT; AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOMARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE;

EID: 84929614733     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.016     Document Type: Article

References (44)

1. Chan P.H. Role of oxidants in ischemic brain damage. Stroke 1996, 27:1124-1129.
2. El Kossi M.M.H., Zakhary M.M. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000, 31:1889-1892.
3. Cherubini A., Ruggiero C., Polidori C.M., Mecocci P. Potential markers of oxidative stress in stroke. Free Radical Biol. Med. 2005, 39:841-852.
4. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J.Neurosci. 1998, 18:205-213.
5. Fujimura M., Morita-Fujimura Y., Kawase M., Copin J.C., Calagui B., Epstein C.J., Chan P.H. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J.Neurosci. 1999, 19:3414-3422.
6. Mertens A., Verhame P., Bielicki J., Phillips M., Quarck R., Verreth W., Strengel D., Ninio E., Navab M., Mackness B., Mackness M., Holwoet P. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003, 107:1640-1646.
7. Ng D.S. The role of LCAT in atherosclerosis. Biochemistry of Atherosclerosis 2006, vol. XV:23-38. (chapter 2).
8. Alamdari D.H., Paletas K., Pegiou T., Sarigianni M., Befani C., Koliakos G. Anovel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin. Biochem. 2007, 40:248-254.
9. Erel O. Anew automated colorimetric method for measuring total oxidant status. Clin. Biochem. 2005, 38:1103-1111.
10. Erel O. Anovel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 2004, 37:277-285.
11. Girotti M.J., Khan N., Mc Lellan B.A. Early measurement of systemic lipid peroxidation products in plasma of major blunt trauma patients. J.Trauma 1991, 31:32-35.
12. Auclair C., Voisin E. Nitroblue tetrazolium reduction. CRC Handbook of Methods for Oxygen Radical Research 1985, 123-132. CRC Press, Boca Raton, FL. R.A. Greenwald (Ed.).
13. Gay C.A., Gebicki J.M. Measurement of protein and lipid hydroperoxides in biological systems by ferric-xylenol orange method. Anal. Biochem. 2003, 315:29-35.
14. Witko-Sarsat V., Nguyen M., Capeillere-Blandin C., Nguyen A.T., Zingraff J. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49:1304-1313.
15. Richter R.J., Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999, 9:745-753.
16. Misra H.P., Fridovich I. Chemistry and metabolism of substances of low molecular weight: the role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J.Biol. Chem. 1972, 247:3170-3175.
17. Ellman G.I. Tissue sulfhydril groups. Arch. Biochem. Biophys. 1959, 82:70-77.
18. Vergeer M., Holleboom A.G., Kastelein J.P., Kuivenhoven J.A. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?. J.Lipid Res. 2010, 51(8):2058-2073.
19. Wannamethee S.G., Shaper A.G., Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000, 31:1882-1888.
20. Araujo aB., Chiu G.R., Christian J.B., Kim H.Y., Evans W.J., Clark R.V. Longitudinal changes in high-density lipoprotein cholesterol and cardiovascular events in older adults. Clin. Endocrinol. 2014, 80(5):662-670.
21. Bots M.L., Elwood P.C., Nikitin Y., Salonen J.T., Concalves A.F., Inzitari D., Sivenius J., Benetou V., Tuomilehto J., Koudstaal P.J., Grobbee D.E. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J.Epidemiol. Community Health 2002, 56:i19-i25.
22. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004, 84:1381-1478.
23. Szöcs K., Lassègue B., Hilenski L.L., Valppu L., Couse T.L., Wilcox J.N., Quinn M.T., Lambeth D.J., Griendling K.K. Upregulation of NOX-based NADPH oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 2002, 22:21-27.
24. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87:840-844.
25. Braughler J.M., Hall E.D. Central nervous system trauma and stroke: I- biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biol. Med. 1989, 6:289-301.
26. Chan P.H. Role of oxidants in ischemic brain injury. Stroke 1996, 27:1124-1129.
27. Bruce-Keller A.J., Li Y.-J., Lovell A., Kramer P.J., Gray D.S., Brown R.R., Marksberry W.R., Mattson M.P. 4-hydroxinonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visio-spatial memory in rat. J.Neuropathol. Exp. Neurol. 1998, 57:257-267.
28. Madamanchi, Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:29-38.
29. Facchineti F., Dawson V.L., Dawson T.M. Free radicals as mediators of neuronal injury. Cell. Mol. Neurobiol. 1998, 18:667-682.
30. Warner D.S., Sheng H., Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J.Exp. Biol. 2004, 207:3221-3231.
31. Fukui S., Ookawara T., Nawashiro H., Suzuki K., Shima K. Post-ischemic transcriptional and translational responses of EC-SOD in mouse brain and serum. Free Radical Biol. Med. 2002, 32:289-298.
32. Namba K., Takeda Y., Sunami K., Hirakawa M. Temporal profile of the levels of endogenous antioxidants after four-vessel occlusion in rats. J.Neurosurg. Anesthesiol. 2001, 13:131-137.
33. Kontush A., Chapman J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006, 58:342-374.
34. Kontush A., Cotta de Faria E., Chantepie S., Chapman J.M. Anormotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 2005, 285:277-285.
35. Jarvik G.P., Rozek L.S., Brophy V.H., Hatsukami T.S., Richter R.J., Schellenberg G.D., Furlong C.E. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2441-2447.
36. Voetsch B., Benke K.S., Damasceno B.P., Siqueira L.H., Loscalzo J. Paraoxonase 192 Gln-Arg polimorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002, 33:1459-1464.
37. Guo J.M., Liu A.J., Su D.F. Genetics of stroke. Acta Pharm. Sin. 2010, 31:1055-1064.
38. Rozenberg O., Aviram M. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem. Biophys. Res. Commun. 2006, 351:492-498.
39. Kotur-Stevuljevic J., Spasic S., Stefanovic A., Zeljkovic A., Bogavac-Stanojevic N., Kalimanovska-Ostric D., et al. Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population. Clin. Chem. Lab. Med. 2006, 44:1206-1213.
40. Liu T., Zhang X., Zhang J., Liang Z., Cai W., Huang M., Yan C., Zhu Z., Han Y. Association between PON1 rs662 polymorphism and coronary artery disease. Eur. J. Clin. Nutr. 2014, 68:1029-1035.
41. Parizadeh M.R., Azarpazhooh M.R., Mobarra N., Nematy M., Alamdari D.H., Tavalaie S., Sahebkar A., Hassankhani B., Ferns G., Ghayour-Mobarhan M. Prooxidant-antioxidant balance in stroke patients and 6-month prognosis. Clin. Lab. 2011, 57:183-191.
42. Kotur-Stevuljevic J., Memon L., Stefanovic A., Spasic S., Spasojevic-Kalimanovska V., Bogavac-Stanojevic N., et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin. Biochem. 2007, 40:181-187.
43. Gugliucci A., Caccavello R., Kotani K., Sakane N., Kimura S. Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function. Clin. Chim. Acta 2013, 415:162-168.
44. Zeljkovic A., Vekic J., Spasojevic-Kalimanovska V., Jelic-Ivanovic Z., Bogavac-Stanojevic N., Gulan B., Spasic S. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis 2010, 210:548-554.